A Drug-Responsive and Protease-Resistant Peripheral NADH Oxidase Complex from the Surface of HeLa S Cells
- 1 October 1998
- journal article
- Published by Elsevier in Archives of Biochemistry and Biophysics
- Vol. 358 (1) , 125-140
- https://doi.org/10.1006/abbi.1998.0823
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- The antitumor sulfonylurea N-(4-methylphenylsulfonyl)-N′-(4-chlorophenyl) urea (LY181984) inhibits NADH oxidase activity of HeLa plasma membranesBiochimica et Biophysica Acta (BBA) - Biomembranes, 1995
- Identification of antitumor sulfonylurea binding proteins of HeLa plasma membranesBiochimica et Biophysica Acta (BBA) - Biomembranes, 1995
- HeLa plasma membranes bind the antitumor sulfonylurea LY181984 with high affinityBiochimica et Biophysica Acta (BBA) - General Subjects, 1995
- Differential response of the NADH oxidase of plasma membranes of rat liver and hepatoma and HeLa cells to thiol reagentsJournal of Bioenergetics and Biomembranes, 1995
- Stimulation of NADH oxidase activity from rat liver plasma membranes by growth factors and hormones is decreased or absent with hepatoma plasma membranesBiochemical Journal, 1992
- A growth factor- and hormone-stimulated NADH oxidase from rat liver plasma membraneBiochimica et Biophysica Acta (BBA) - Biomembranes, 1992
- NADH oxidase of plasma membranesJournal of Bioenergetics and Biomembranes, 1991
- NADH oxidase of liver plasma membrane stimulated by diferric transferrin and neoplastic transformation induced by the carcinogen 2-acetylaminofluoreneBiochimica et Biophysica Acta (BBA) - Bioenergetics, 1991
- Novel agents effective against solid tumors: the diarylsulfonylureas. Synthesis, activities, and analysis of quantitative structure-activity relationshipsJournal of Medicinal Chemistry, 1990
- Clinical pharmacology of a novel diarylsulfonylurea anticancer agent.Journal of Clinical Oncology, 1989